Last reviewed · How we verify
Dexmedetomidine Injectable Solution
At a glance
| Generic name | Dexmedetomidine Injectable Solution |
|---|---|
| Also known as | Precedex, Hospira, Dexmedetomidine |
| Sponsor | Wayne State University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dexmedetomidine for Invasive Ventilation In the NEOnate (PHASE2, PHASE3)
- Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery (PHASE2)
- Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (NA)
- PENG Block With Dexmedetomidine in Older Adults (NA)
- Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors (PHASE2, PHASE3)
- Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery (PHASE4)
- Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA (NA)
- Dexmedetomidine vs Ketamine as Adjuvants to Bupivacaine in Transversus Abdominus Plane Block in Inguinal Hernioplasty (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |